Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The cannula market is expected to expand at a CAGR of 6.7% from 2018 to 2030, and it is expected to reach $286.4 billion in terms of total market value.
Many important factors determine the dynamics and development trajectory of the cannula market. The rise in chronic diseases and resultant surgeries is one of such drivers for this industry. Medical procedures requiring cannulation like intravenous administration, oxygen therapy as well as other medical emergencies are rising due to global ageing population and increased prevalence of lifestyle-related health problems.
The cannula market also greatly depends on technological advances. Manufacturing, design, and material science have led to better and more user-friendly cannulas. Cannula performance, patient comfort as well as complication rates are positively influenced by these technological advancements thus driving forward healthcare providers/institutions that are willing to utilize state-of-the-art technologies.
Also contributing to its advancement is an increasing level of public awareness about healthcare issues at large. Cannulas have grown popular with patients paying closer attention being given towards understanding their benefits among other reasons. Cannulas among other medical interventions are subject to input from patients because people now know better why they should take part in making decisions concerning healthcare.
Economic factors play a very significant role in defining the sensitivity level of the cannula market.In relation to global economic growth depending on what each region’s health infrastructure plus spending capability looks like. Surgical operations are on the rise with access to medical facilities in developing nations due to an increase in health spending. Cannulas, therefore, enjoy high demand. On the other hand, during tough economic times healthcare spending is reduced giving less funds for innovative devices such as cannulas.
The dynamics of the cannula market are influenced by many competitive variables, including healthcare sector mergers, acquisitions, and partnerships. In order to diversify their product portfolios, improve their technical skills and gain an edge in the market place; companies seek strategic alliances. These strategic moves also affect how market penetration as well as pricing tactics of a given industry make up its market structure.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Growth Rate | 6.7% (2022-2030) |
Cannula Market Highlights:
Global Cannula Market Overview
Cannula Market Size was valued at USD 187.00 Billion in 2023. The Global Cannula industry is projected to grow from USD 200.00 Billion in 2024 to USD 298.00 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.10% during the forecast period (2024 - 2032).
A cannula is a small hollow tube with a sharpened and retractable inner core that is inserted into a vein, artery, or body cavity to deliver medication and remove fluids.
Cannulae are available for a range of procedures. During heart surgery, for example, an intravenous cannula is used to achieve cardiopulmonary bypass. A nasal cannula is used to supply oxygen by placing the plastic tubing behind the nose. It's also commonly used for filler injections because it's less painful, reduces the danger of bleeding and bruising, and has more flexibility than hypodermic needles. It is frequently utilized in hospitals, ambulatory surgery centers (ASCs), blood banks, laboratories, and pathology laboratories all over the world due to its many qualities.
The growing number of surgeries, innovations in healthcare facilities, more investment in research & development, a large patient pool, and rising government funding are the major factors driving this market. A primary driver of this business is the expanding usage of minimally invasive surgery (MIS) therapies.
In July 2022, B. Braun Medical Inc., a prominent player in infusion therapy, unveiled its latest product, the Introcan Safety 2 IV Catheter, with a unique one-time blood control mechanism. The Introcan Safety 2 IV Catheter, developed by B. Braun, aims to enhance the safety of IV access for healthcare professionals by minimizing the likelihood of needlestick injuries and potential blood exposure. The establishment of intravenous (IV) access is a crucial component of infusion therapy, and this invasive technique remains linked to possible hazards for healthcare providers.
Clinicians confront a significant risk of needlestick injuries in their regular practice. According to the CDC, there are around 385,000 incidents of sharps injuries annually, with more than 30% of these resulting from hollow-bore needles, such as those employed in peripheral IV catheters (PIVCs).
Research indicates that passive, fully automated safety systems exhibit double the effectiveness of a semi-automatic 'push-button' safety shield and three times the effectiveness of a manually sliding barrier. The Introcan Safety 2 provides clinicians with a fully automated passive safety mechanism, ensuring their protection. Healthcare personnel have concerns about both needlestick injuries and mucocutaneous blood exposure while initiating an IV. Indeed, the majority of nurses expressed apprehension regarding blood exposure, both in terms of their personal safety and the safety of their patients.
In certain international markets, Shockwave Medical has unveiled its new coronary intravascular lithotripsy (IVL) catheter in May 2023. The Shockwave C²⁺ IVL catheter is designed for the management of highly calcified coronary artery disease. The commercial availability of Shockwave C²⁺ for the treatment of de novo coronary artery disease is currently accessible in Europe and certain other regions. It is purported to provide a 50% increase in the number of pulses per catheter compared to Shockwave C².
Additionally, it is designed to effectively treat longer calcified lesions, as well as complex eccentric and nodular calcium formations. Shockwave C²⁺ retains the user-friendly catheter design and ease of use that have been crucial to the success of Shockwave IVL. It also includes enhancements that will improve procedural efficiency and optimize the treatment of complex morphologies.
Cannula Market Segment Insights
The Cannula market has been segmented into product, material, application and end user.
Cannula Product Insights
The market, on the basis of product, has been segmented into cardiac cannulas, nasal cannulas, vascular cannulas, dermatology cannulas, arthroscopy cannulas and others.
Cannula Material Insights
The market, by material, has been segmented into plastic (PVC), silicone and metal (stainless steel).
Cannula Application Insights
The market, by application, has been segmented into cardiovascular surgery, oxygen therapy, general surgery, plastic/cosmetic surgery, orthopaedic surgery and others.
Cannula End User Insights
The market, by end user, has been segmented into hospitals, ambulatory surgical centers and others. The hospitals segment is anticipated to hold the largest market share owing to increase in hospitalizations and large number of surgeries in hospitals. The ambulatory surgical centers are expected to grow at the highest CAGR owing to the increasing demand for modern healthcare facilities.
Cannula Regional Insights
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Cannula Market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European Market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Cannula market in the Middle East & Africa has been segmented into the Middle East and Africa.
Cannula Market Top Key Players
Some of the key players in the Cannula market are
- Medtronic
- Edwards Lifesciences Corporation
- Terumo Cardiovascular Systems Corporation
- LivaNova PLC
- Smith & Nephew
- CONMED Corporation
- Smiths Medical
- Teleflex Incorporated
- Boston Scientific Corporation
- McKesson Medical-Surgical Inc.
- Harsoria Healthcare Pvt. Ltd.
- ISPG Inc.
- ILIFE MEDICAL DEVICES PRIVATE LIMITED (India)
- Denex International
- BD
Regional Market Summary
Geographically, the Americas is anticipated to dominate the Cannula market owing to rising healthcare expenditure, increase in number of surgeries and developing healthcare infrastructure. According to Centers Medicare and Medicaid Services, National Healthcare Expenditure grew by 4.3% to USD 3.3 trillion in 2016 from the previous year. Europe is expected to hold the second largest position in the market. The market growth in this region is attributed to the government support and improving healthcare related research & development activities. The Cannula Market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the increasing demand for minimally invasive surgeries and rising healthcare spending. According to the World Bank Group, India spent 3.89% of its Gross Domestic Product (GDP) on health. The Middle East & Africa are expected to hold the least share of the market. The market growth in this region is expected to be driven by a developing healthcare infrastructure.
Recent Development
LivaNova announced Bi-Flow, a novel range of femoral artery cannulas that allows stable bidirectional perfusion and is the only femoral arterial cannula that prevents limb ischemia, in July 2019. Europe and Canada are among the markets where this new equipment is accessible. In addition, the corporation plans to extend its market in the United States, thereby boosting its industry share. Terumo Blood and Cell Technologies' (Terumo BCT) unique plasma collection technology was authorized by the US Food and Drug Administration (FDA) in March 2022. Terumo BCT is a medical technology company that leads the cannula market. Rika is a next-generation automated technology designed to improve the experience of plasma facility employees and donors. Rika was founded in response to the industry's need for technological advancement and process optimization to boost productivity and quality while maintaining donor safety and a sufficient plasma supply.
Cannula Market Segmentation
Cannula Product Outlook
- Cardiac Cannulas
- Nasal Cannulas
- Vascular Cannulas
- Dermatology Cannulas
- Arthroscopy Cannulas
- Others
Cannula Material Outlook
- Plastic (PVC)
- Silicone
- Metal (Stainless Steel)
Cannula Application Outlook
- Cardiovascular Surgery
- Oxygen Therapy
- General Surgery
- Cosmetic/Plastic Surgery
- Orthopedic Surgery
- Others
Cannula End User Outlook
- Hospitals
- Ambulatory Surgical Centers
- Others
Cannula Regional Outlook
- Americas
- North America
- US
- Canada
- South America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- The Middle East & Africa
- Middle East
- Africa
Intended Audience:
- Medical Device Suppliers
- Research and Development Organization
- Medical Device Manufacturers
- Healthcare Organizations
- Academics and Research Institutes
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
